News
Wall Street Analysts See a 41.11% Upside in Treace Medical Concepts (TMCI): Can the Stock Really Move This High?
Treace Medical Concepts (TMCI) closed the last trading session at $7.20, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts See a 51.77% Upside in Inspired Entertainment (INSE): Can the Stock Really Move This High?
Inspired Entertainment (INSE) closed the last trading session at $8.17, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Believe Intapp (INTA) Could Rally 26.09%: Here's is How to Trade
Shares of Intapp (INTA) have gained 7.3% over the past four weeks to close the last trading session at $56.31, but there could still be a solid upside left in the stock if short-term price targets
Can Honest (HNST) Climb 40.83% to Reach the Level Wall Street Analysts Expect?
Shares of Honest (HNST) have gained 14.5% over the past four weeks to close the last trading session at $5.07, but there could still be a solid upside left in the stock if short-term price targets
Does Kemper (KMPR) Have the Potential to Rally 25.46% as Wall Street Analysts Expect?
Shares of Kemper (KMPR) have gained 12.8% over the past four weeks to close the last trading session at $65.52, but there could still be a solid upside left in the stock if short-term price targets
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?
Mind Medicine (MindMed) Inc. (MNMD) closed the last trading session at $6.45, gaining 16.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Think Centrus Energy (LEU) Could Surge 56.61%: Read This Before Placing a Bet
Centrus Energy Corp. (LEU) closed the last trading session at $94.71, gaining 46% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade
Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade
Shares of ClearPoint Neuro, Inc. (CLPT) have gained 18.2% over the past four weeks to close the last trading session at $13.64, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade
Cogent Biosciences, Inc. (COGT) closed the last trading session at $5.13, gaining 12% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Think AudioEye (AEYE) Could Surge 73.64%: Read This Before Placing a Bet
Shares of AudioEye (AEYE) have gained 14.3% over the past four weeks to close the last trading session at $12.90, but there could still be a solid upside left in the stock if short-term price
Can Easterly Government Properties (DEA) Climb 35.04% to Reach the Level Wall Street Analysts Expect?
Shares of Easterly Government Properties (DEA) have gained 0.1% over the past four weeks to close the last trading session at $20.92, but there could still be a solid upside left in the stock if
Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know
Ardent Health Partners, Inc. (ARDT) closed the last trading session at $14.83, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
How Much Upside is Left in Clearfield (CLFD)? Wall Street Analysts Think 26.51%
Clearfield (CLFD) closed the last trading session at $36.36, gaining 37.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Predict a 156.09% Upside in Beyond (BYON): Here's What You Should Know
Shares of Beyond (BYON) have gained 30.8% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets
Can BioLife Solutions (BLFS) Climb 30.68% to Reach the Level Wall Street Analysts Expect?
Shares of BioLife Solutions, Inc. (BLFS) have gained 8.2% over the past four weeks to close the last trading session at $23.89, but there could still be a solid upside left in the stock if
Wall Street Analysts Predict a 57.47% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
Shares of Abacus Life, Inc. (ABL) have gained 7.5% over the past four weeks to close the last trading session at $8.70, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to Trade
BridgeBio Pharma (BBIO) closed the last trading session at $35.68, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
After Golden Cross, Telefonica Brasil (VIV)'s Technical Outlook is Bright
Telefonica Brasil S.A. (VIV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VIV's 50-day simple moving average crossed
Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now
Shares of Astellas Pharma Inc. (ALPMY) have been struggling lately and have lost 7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that
ACCESS Newswire Inc. (ACCS) Q1 Earnings and Revenues Miss Estimates
ACCESS Newswire Inc. (ACCS) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ago
Here's Why Investors Should Consider Retaining Xylem Stock Now
Xylem Inc. XYL is witnessing strength in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. Growth in
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
PTC Inc. (PTC) is a Top-Ranked Momentum Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research